Samuel Wadsworth, Ph.D.
Board Member
Precision Biosciences Inc (DTIL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Samuel Wadsworth, Ph.D.
Samuel Wadsworth, Ph.D. is recorded as Board Member at Precision Biosciences Inc (DTIL). Precision Biosciences Inc reported in an 8-K filed January 29, 2025 that Samuel Wadsworth, Ph.D. resigned as Board of Directors, effective January 23, 2025. Precision Biosciences Inc reported in an 8-K filed June 10, 2024 that Samuel Wadsworth, Ph.D. was appointed Class II director, effective June 4, 2024.
“On January 23, 2025, Sam Wadsworth, Ph.D., notified Precision BioSciences, Inc. (the “Company”) of his intention to retire from service on company boards and resigned from the Company’s Board of Directors.”
“Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. were elected as Class II directors, and Item 2, Item 3, and Item 4 were approved.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-04–present
-
2021-11-08–2025-01-23
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Precision Biosciences Inc
Other people whose current roles at this company are on record from its filings.
- Matthew Kane CEO
- Naresh Tanna CFO
- Alex Kelly COO, Chief Accounting Officer
- Dario Scimeca General Counsel
- Mei Burris Chief Accounting Officer
- Shane Barton Chief Accounting Officer
- Geno Germano Board Member
- Melinda Brown Board Member
- Michael Amoroso Board Member
- Samuel Wadsworth Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.